Vaccine Technology IV
December 15, 2011
Co-Chairs:
Paula M. Alves
IBET/ITQB
Portugal
John G. Auniņš
Jānis Biologics, LLC
USA
Barry C. Buckland
University College
London
UK
Kathrin U. Jansen
Pfizer
USA
Session Topics:
Vaccine Target Identification and Validation
Session co-chairs:
George Siber, Genocea, USA
David Weiner, University of Pennsylvania, USA
Bioprocess Development and Analytical Tools
Session co-chairs:
Luis Maranga, Novartis Vaccines & Diagnostics, Inc., USA
Mike Washabaugh, Astra Zeneca, USA
Late Stage and Recently Launched Vaccines
Session co-chairs
Nathalie Garçon, GlaxoSmithKline, Belgium
Kathrin Jansen, Pfizer, USA
Veterinary Vaccines
Session co-chairs:
Robert Nordgren, Merial, USA/France
Ian Tarpey, Merck Animal Health, UK
New Technologies and Approaches
Session co-chairs:
Mike Hoare, University College London, UK
Herve Pinton, Sanofi Pasteur, France
Technology Challenges in the Developing World
Session co-chairs:
Leda Castilho, Federal Univ. of Rio de Janeiro, Brasil
Paula Alves, Instituto Biologia Experimental e Tecnologica, Portugal
Oncology and Therapeutic Vaccines
Session co-chairs:
John G. Auniņš, Jānis Biologics LLC, USA
Amine Kamen, Biotechnology Research Institute, National Research Council of Canada
Biodefense, Pandemic and Emerging Disease Vaccines
Session co-chairs:
Barry Buckland, University College, London, UK
Phil Gomez, Price Waterhouse Coopers, USA
Vaccine Stability, Characterization and Delivery?
Session co-chairs:
Debbie Drane, CSL Limited, Australia
Robert Evans, Merck Sharp & Dohme Research Laboratories, USA
Laura Palomares, Universidade Nacional Autonomous de Mexico
Confirmed Keynote Speakers
Julie Gerberding, Merck Sharp & Dohme, USA
Stephen Russell, Mayo Clinic, USA
Poster Chairs:
Tarit K. Mukhopadhyay, University College London, UK
Hela Kallel, Institute Pasteur in Tunis, Tunisia